Survivors of the 2003 SARS epidemic were found to have higher rates of adverse mental conditions. This study aimed to assess cognitive function in women delivering during the COVID-19 pandemic, as compared to women who delivered before the COVID-19 pandemic. A cohort study was performed during the immediate postpartum period of women delivering singletons at term. Cognitive function was assessed using an objective neurocognitive test (Symbol Digit Modalities Test SDMT90, SDMT4) and a subjective self-estimation questionnaire (Attention Function Index AFI). The exposed group was recruited during the COVID-19 outbreak in Israel (May 2020), whereas the comparison group consisted of women delivering at the same medical center before the COVID-19 pandemic (2016–2017). Multivariable regression models were constructed to control potential confounders. There were 79 parturients recruited during the COVID-19 pandemic and compared with 123 women who delivered before the COVID-19 pandemic. Women delivering during the COVID-19 pandemic scored lower in the subjective AFI test compared to the unexposed group (70.0 ± 15.4 vs. 75.1 ± 14.7, p = 0.018). However, no significant difference was found in the objective SDMT tests scores. These results remained similar in the multivariable regression models when controlling for maternal age, ethnicity and time from admission to assessment, for AFI, SDMT90 and SDMT4 scores (p = 0.014; p = 0.734; p = 0.786; respectively). While no significant difference was found in objective tests, our findings propose that the exposure to the COVID-19 pandemic is independently associated with a significant decrease in subjective maternal cognitive function during the immediate postpartum period.
Objective. Cardiovascular disease remains one of the leading causes of morbidity and mortality worldwide, highlighting the need for accurate risk prediction. Atrial fibrillation burden (AFB), premature ventricular contraction burden (PVCB), and T-wave alternans (TWA) have been individually associated with adverse outcomes. We hypothesized that these three digital ECG biomarkers provide complementary prognostic information for major cardiovascular endpoints and all-cause mortality (ACM), and developed a machine learning approach combining these biomarkers for risk prediction. Approach. We analyzed 81 362 Holter recordings from 54 395 individuals across 20 primary care centers in Israel. A random forest model using AFB, PVCB, TWA, and age was trained to predict 5 year risk of heart failure (HF), ischemic stroke (IS), and ACM. Main results. On the test set, best AUROCs were for HF 0.75 [95% CI: 0.74–0.77] ( ), for IS 0.69 [0.66–0.71] ( ), and for ACM 0.79 [0.77–0.80] ( ). Combining the three ECG-derived biomarkers showed complementary predictive value and improved discrimination by up to 10% over age alone in individuals aged years. Significance. AFB, PVCB, and TWA contribute complementary prognostic information for risk stratification. When combined with age, these biomarkers improve predictive performance compared with age alone.